Use of digoxigenin-labelled probes for the quantitation of HBV-DNA in antiviral drug evaluation

Journal of Virological Methods

Volumn 81, Issue 1-2, 1999, Pages 155-158

  Ying, C ^a   Van Pelt, J ^b   Yap, S H ^b   De Clercq, E ^a   Neyts, J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Antivirals; Digoxigenin; Drug evaluation; HBV

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; DIGOXIGENIN; LAMIVUDINE; LOBUCAVIR; PENCICLOVIR; PRIMER DNA; TENOFOVIR; UNCLASSIFIED DRUG; VIRUS DNA;

ACCURACY; ANIMAL CELL; ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DNA BINDING; DNA HYBRIDIZATION; DOSE RESPONSE; HEPATITIS B VIRUS; HEPATOMA CELL; IN VITRO STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SHORT SURVEY; TECHNIQUE;

HEPATITIS B VIRUS;

EID: 0032779259     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(99)00070-1     Document Type: Article

References (7)

1. Acs G., Sells M.A., Purcell R.H., Price P., Engle R., Shapiro M., Popper M. Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc. Natl. Acad. Sci. USA. 84:1987;4641-4644.
2. An S.F., Franklin D., Fleming K.A. Generation of digoxigenin-labelled double-stranded and single-stranded probes using the polymerase chain reaction. Mol. Cell. Probes. 6:1992;193-200.
3. Ganem D. Hepadnaviridae and their replication. Fields B.N., Knipe D.M., Howley P.M. et al. Fields Virology. 1996;Lippincott-Raven, Philadelphia.
4. Hoofnagle J.H. Therapy of viral hepatitis. Digestion. 59:1998;563-578.
5. Ladner S.K., Otto M.J., Barker C.S., Zaifert K., Wang G.-H., Guo J.-T., Seeger C., King R.W. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41:1997;1715-1720.
6. Niesters H.G.M., Honkoop P., Haagsma E.B., de Man R.A., Schalm S.W., Osterhaus A.D.M.E. Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. J. Infect. Dis. 177:1998;1382-1385.
7. Pillay D., Bartholomeusz A., Cane P., Mutimer D., Schinazi R.F., Locarnini S. Mutations in the hepatitis B virus DNA polymerase associated with antiviral resistance. Int. Antiviral News. 6(9):1998;167-169.